Physician

George Nicholas Logothetis, M.D.

According to 2025 Medicare claims, George Logothetis, M.D. (NPI: 1619966223) practices cardiology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1972906667; TIN: 23-2730785) and primary practice location at 17325-2516. Logothetis is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Logothetis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,690 traditional Medicare patients, billed 19,939 HCPCS/CPT codes, and received $338,215 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,954 prescription claims across 1,248 beneficiaries totaling $1,151,733 in drug costs, led by Eliquis (Apixaban). DME data shows 29 claims. Open Payments data shows 15 records totaling $476. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $499,606 to $338,215. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $604,766 and ending at $1,151,733. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,662 and ending at $43,614.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,389	17,566	$499,606
2016	1,097	17,901	$537,803
2017	1,313	15,316	$484,586
2018	1,078	14,417	$519,353
2019	1,479	6,020	$253,445
2020	1,152	2,790	$194,098
2021	2,453	5,752	$275,890
2022	2,731	11,469	$320,430
2023	2,560	17,680	$359,610
2024	2,690	19,939	$338,215

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	458	6,037	$604,766
2016	474	6,346	$801,806
2017	512	7,162	$804,530
2018	539	7,105	$816,739
2019	574	5,454	$708,897
2020	484	2,693	$364,346
2021	576	3,847	$466,568
2022	975	6,296	$1,001,633
2023	970	6,672	$1,077,795
2024	1,248	6,954	$1,151,733

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	180	725	$28,205
2016	160	588	$27,608
2017	124	583	$13,989
2018	132	525	$11,546
2019	123	555	$26,653
2020	23	344	$26,333
2021	N/R	151	$6,337
2022	N/R	72	$3,628
2023	N/R	38	$2,439
2024	N/R	29	$42,411

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	681	1,085	$84
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	742	758	$59
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	163	163	$51
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	954	1,040	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,251	1,782	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	632	30,658	$576,959
Xarelto	Rivaroxaban	112	8,481	$149,715
Jardiance	Empagliflozin	111	6,435	$109,339
Entresto	Sacubitril/Valsartan	71	3,405	$69,652
Farxiga	Dapagliflozin Propanediol	27	1,710	$30,567

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	17	$41,082
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,329

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$476	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George Nicholas Logothetis, M.D.?

Tedicare shows public-source Medicare data for George Nicholas Logothetis, M.D. (NPI 1619966223), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George Nicholas Logothetis, M.D. have ACO affiliation data?

George Nicholas Logothetis, M.D. is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to George Nicholas Logothetis, M.D.?

George Nicholas Logothetis, M.D. is linked to WELLSPAN MEDICAL GROUP (billing NPI 1972906667) in the available physician profile data.

Does George Nicholas Logothetis, M.D. have Open Payments data?

George Nicholas Logothetis, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.